Organization Profile

You just read:

EMD Serono Receives Health Canada Notice of Compliance for MAVENCLAD™ (cladribine tablets) for patients living with relapsing-remitting multiple sclerosis (RRMS)

News provided by

EMD Inc.

Dec 04, 2017, 09:15 ET